Verrica Pharmaceuticals Reports Third Quarter 2025 Financial Results
– Company reports $14.3 million in revenue in Q3’25, consisting of $3.6…
CORRECTION – POET Technologies Reports Third Quarter 2025 Financial Results
November 13, 2025 18:16 ET | Source: POET Technologies Inc. TORONTO, Nov.…
Cypherpunk Technologies (formerly Leap Therapeutics) Reports Third Quarter 2025 Financial Results
CAMBRIDGE, Mass., Nov. 12, 2025 /PRNewswire/ -- Cypherpunk Technologies Inc., previously known as…
Los Angeles Influence Reports on LuxUrban Bankruptcy and Payment Platform Issues
New York, NY, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Newly surfaced documents…
Wuxi Xishan Golden Autumn Investment and Cooperation Symposium Reports Strong Outcomes
WUXI, China, Nov. 9, 2025 /PRNewswire/ -- The 2025 Wuxi Xishan Golden…
Senores Pharma Reports Strong Q2 & H1 FY26 Performance, Sustains Growth Momentum Across Businesses
AHMEDABAD, India, Nov. 7, 2025 /PRNewswire/ -- Senores Pharmaceuticals Limited continued its strong…
Aarti Industries Reports Sequential Growth in Q2 FY26; Focuses on Innovation, Integration and ESG
MUMBAI, India, Nov. 6, 2025 /PRNewswire/ -- Aarti Industries Limited (AIL), a…
SEMI Reports Worldwide Silicon Wafer Shipments Increase 3% Year-on-Year in Q3 2025
Growth in 300 mm Shipments Fueled by AI to Support Advanced Logic,…
Nanoscope Therapeutics Reports Five-Year Safety Results from Phase 1/2a Follow-Up Study of MCO-010 Optogenetic Therapy in Retinitis Pigmentosa
DALLAS, Nov. 4, 2025 /PRNewswire/ -- Nanoscope Therapeutics Inc. announced today positive…
FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
October 31, 2025 16:30 ET | Source: FibroBiologics, Inc. Advancing preparations to…
